Scientific Program – ART/IVF/Infertility

Friday, November 28 & Saturday, November 29, 2025

Friday, November 28

08:30-09:00 GOOD MORNING ROME PLENARY LECTURE HALL A
Chairpersons Zion Ben Rafael, Israel
Rene Frydman, France
08:30-08:55 Pioneering uterus transplantation: Reflections on breakthroughs and deliveries
Mats Brännström, Sweden
08:55-09:00 Discussion

 

09:00-10:00 OVARIAN STIMULATION PRACTICES HALL A
Capsule Treatment of low and high responders
Chairpersons Zion Ben Rafael, Israel
Rene Frydman, France
09:00-09:30

09:00
09:10
09:20

Debate: Double trigger: When? Why? Does it work?

Yes: TBA
No: Anja Pinborg, Denmark
Discussion
09:30-10:00

09:30
09:40
09:50

Debate: Should we go straight to IVF in women with anovulation due to PCOS?

No: Stefano Palomba, Italy
Yes: Norbert Gleicher, USA
Discussion

 

10:00-10:30 Coffee break, visit the exhibition, and e-poster viewing

 

10:30-12:00 IPREPARATION FOR IVF HALL A
Capsule
Chairpersons  
10:30-11:00

10:30
10:40
10:50

Debate: Should we screen for chronic endometritis before ART?

No: Paul Pirtea, France
Yes: 
Discussion
11:00-11:30

11:00
11:10
11:20

Debate: The debate goes on: PRP for rejuvenation to improve ovarian response

Yes: Safety and efficacy based on a single centre experience Mattheos Fraidakis, Greece
No: Results of the PROVA RCT Norbert Gleicher, USA
Discussion
11:30-11:40 Artificial Intelligence will decide the future of embryo selection?
Laura Rienzi, Italy
11:40-11:45 Discussion
11:45-11:55 Ovulation trigger: How should we personalize?
Michael Grynberg, France
11:55-12:00 Discussion

 

12:00-12:05 Short break

 

12:05-13:05 INDUSTRY SUPPORTED SESSION HALL A

 

13:05-14:00 Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions

 

14:00-15:00 INDUSTRY SUPPORTED SESSION HALL A

 

15:00-15:05 Short break

 

15:05-16:35 TBA HALL A
Capsule
Chairpersons

 

16:35-17:00 Coffee break, visit the exhibition, and e-poster viewing

 

17:00-18:30 PERSONALIZED MEDICINE HALL A
Capsule
Chairpersons

17:00-17:15

 The challenges of defining success in ART
Luca Gianaroli, Italy   

17:15-17:20

 Discussion

17:20-17:50

17:20
17:30
17:40

Debate: Ovarian stimulation

Proposition: Personalization of ovarian stimulation TBA
Opposition: Edgardo Somigliana, Italy
Discussion

17:50-18:20

17:50
18:00
18:10

Debate: Should we treat istmocele in infertile women, and how?

Yes: Amerigo Vitagliano, Italy
No: Mauro Cozzolino, Italy
Discussion
18:20-18:30 Discussion

Saturday, November 29

08:30-10:00 GOOD MORNING ROME PLENARY LECTURE HALL A
Capsule
Chairpersons

Bart Fauser, Netherlands
Jacques Donnez, Belgium
08:30-08:55

Endometriosis before and during pregnancy
Paolo Vercellini, Italy
08:55-09:00 Discussion
09:00-10:30 HI-TECH IVF HALL A
Capsule
09:00-09:25

Automation in IVF: Where are we heading
Laura Rienzi, Italy
09:25-09:30

Discussion
09:30-09:55

Imaging of early embryos using a light-sheet on-a-chip device: A proof-of-concept
Fabbrizio Horta Nunez, Australia
09:55-10:00 Discussion
10:05-10:25

Prospects for use of bioengineered tissue from stem cells in gynecology
Mats Brännström, Sweden
10:25-10:30 Discussion

 

10:30-11:00 Coffee break, visit the exhibition, and e-poster viewing

 

11:00-12:30 Q&A HALL A 
Capsule Expert views on hot controversial issues
Chairpersons

Zion Ben Rafael, Israel
Bart Fauser, Netherlands
Discussants

Laura Rienzi, Italy
Anja Pinborg, Denmark
Rita Vassena, Spain
Edgardo Somigliana, Italy
Joop Laven, Netherlands
Norbert Gleicher, USA

Q&A

  1. Luteal supplementation – vaginal oral injectable? is it different and after 40Y?
  2. PRP- for rejuvenation? Any real proof of its efficacy?
  3. Add-ons which one works?
  4. When a high percentage of eggs are immature
  5. When the fertilization rate is low, When blastulation rates are low
  6. Should we embrace the view of aiming for many oocytes to increase chances for a second child from the same stimulation cycle?
  7. Should PGT-A be part of every IVF cycle?
  8. When semen quality is borderline for IVF?
  9. The uterine microbiome: Are the studies credible. Can it predict implantation?
  10. The Artificial cycle for FET: will it survive?
  11. Should we keep using HRT for FET?
  12. Are we losing embryos when applying day 5 culture for IVF?
  13. Timings in the lab vs. outcomes? (OPU to IVF or to ICSI, What sperm selection method is best?)

 

12:30-13:30 Lunch break, visit the exhibition, and e-poster viewing

 

13:30-15:00 LUTEAL PHASE SUPPORT HALL A 
Capsule
Chairpersons

Basil Tarlatzis, Greece
13:30-13:45

Oral, intravaginal, injectable progesterone
Dominique de Ziegler, France
13:45-13:50

Discussion
13:50-14:05

Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: A double-blind crossover study investigating pharmacokinetics and impact on the endometrium
TBA
14:05-14:10

Discussion
14:10-14:40

14:10
14:20
14:30

Debate: Are we losing embryos when applying day 5 culture for IVF?

Yes:
Opposition:  Paul Pirtea, France
Discussion
14:40-14:55

Progesterone supplementation, what else?
TBA
14:55-15:00

Discussion

 

15:00-16:30 HIGH AND LOW RESPONDERS HALL A 
Capsule
Chairpersons

Joop Laven, Netherlands
Edgardo Somigliana, Italy
15:00-15:15

Infertility treatment in women with PCOS – what does the evidence say?
Basil Tarlatzis, Greece
15:15-15:20

Discussion
15:20-15:35

Ovarian stimulation protocols from ultra-long to short: What works best?
Alberto Vaiarelli, Italy
15:35-15:40

Discussion
15:40-15:55

Stimulation of DOR patient
Stratis Kolibianakis, Greece
15-55-16:00 Discussion
16:00-16:30

16:00
16:10
16:20

Debate: LH activity in COS; is it still necessary?

Yes: Paul Pirtea, France
No: Carlo Alviggi, Italy
Discussion

 

Skip to content